Private Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $439K | Buy |
986
+21
| +2% | +$9.34K | 0.04% | 449 |
|
|
2025
Q1 | $468K | Buy |
965
+7
| +0.7% | +$3.39K | 0.05% | 401 |
|
|
2024
Q4 | $386K | Sell |
958
-6
| -0.6% | -$2.42K | 0.04% | 477 |
|
|
2024
Q3 | $448K | Sell |
964
-191
| -17% | -$88.8K | 0.05% | 426 |
|
|
2024
Q2 | $541K | Sell |
1,155
-285
| -20% | -$134K | 0.06% | 350 |
|
|
2024
Q1 | $602K | Buy |
1,440
+104
| +8% | +$43.5K | 0.07% | 325 |
|
|
2023
Q4 | $544K | Buy |
1,336
+12
| +0.9% | +$4.88K | 0.06% | 323 |
|
|
2023
Q3 | $460K | Buy |
1,324
+2
| +0.2% | +$695 | 0.06% | 334 |
|
|
2023
Q2 | $465K | Buy |
1,322
+212
| +19% | +$74.6K | 0.06% | 331 |
|
|
2023
Q1 | $350K | Sell |
1,110
-39
| -3% | -$12.3K | 0.05% | 391 |
|
|
2022
Q4 | $332K | Buy |
1,149
+279
| +32% | +$80.6K | 0.05% | 389 |
|
|
2022
Q3 | $252K | Buy |
870
+496
| +133% | +$144K | 0.04% | 428 |
|
|
2022
Q2 | $105K | Buy |
+374
| New | +$105K | 0.02% | 676 |
|
|
2014
Q4 | – | Sell |
-198
| Closed | -$22K | – | 1161 |
|
|
2014
Q3 | $22K | Hold |
198
| – | – | 0.01% | 819 |
|
|
2014
Q2 | $19K | Buy |
198
+14
| +8% | +$1.34K | 0.01% | 852 |
|
|
2014
Q1 | $13K | Hold |
184
| – | – | ﹤0.01% | 878 |
|
|
2013
Q4 | $14K | Sell |
184
-234
| -56% | -$17.8K | 0.01% | 833 |
|
|
2013
Q3 | $32K | Sell |
418
-353
| -46% | -$27K | 0.01% | 533 |
|
|
2013
Q2 | $62K | Buy |
+771
| New | +$62K | 0.03% | 368 |
|